Form 4 for CLDX Celldex Therapeutics, Inc.
Accepted 2024-11-12 00:00:00 ET · period of report 2024-11-11 · accession 0001415889-24-026489 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-11-12 | 2024-11-11 | CLDX | Marucci Anthony S | Pres, CEO, Dir | P - Purchase | $26.82 | +11.5K | 40.3K | +40% | +$308.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-11-11 | P | A | 11,500 | $26.82 | 40,284 | D | — | — | (F1) Includes 1,092 shares of common stock acquired under the Celldex Therapeutics, Inc. 2004 Employee Stock Purchase Plan. |